Monsanto Plans Independence, Announces New Biotech Projects

August 26, 2002

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal


Monsanto Plans Independence, Announces New Biotech Projects

ST. LOUIS--Monsanto Co. is in the process of spinning off intoan independent company, thereby dividing from Pharmacia Corp., according to aJuly 22 story that appeared in the Chicago Tribune (www.chicagotribune.com).Reportedly, Pfizer Inc. has proposed to buy Pharmacia, which should allowMonsanto to more readily refocus on biotechnology.

Monsanto has two new biotech projects in the pipeline, according to the Tribune.The first is to splice a gene from algae into canola oil, which will reportedlycreate a canola oil high in heart-healthy omega-3s without the fishy taste.Monsanto's second project is to insert amino acids into soybeans and corn for"ideal" animal feed, according to the Tribune.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like